5-year risk of progression to type 2 diabetes in patients with myocardial infarction and overweight or obesity: a cohort study of the preventive potential of semaglutide treatment
Event:
ESC Congress 2025
Topic:
Secondary Prevention
Session:
Secondary prevention (1)
